Cargando…

Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures

BACKGROUND: A pilot programme to treat multidrug-resistant TB (MDR-TB) was implemented in Karakalpakstan, Uzbekistan in 2003. This region has particularly high levels of MDR-TB, with 13% and 40% among new and previously treated cases, respectively. METHODOLOGY: This study describes the treatment pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cox, Helen S., Kalon, Stobdan, Allamuratova, Sholpan, Sizaire, Vinciane, Tigay, Zinaida N., Rüsch-Gerdes, Sabine, Karimovich, Hamraev A., Kebede, Yared, Mills, Clair
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040509/ https://www.ncbi.nlm.nih.gov/pubmed/17987113 http://dx.doi.org/10.1371/journal.pone.0001126

Ejemplares similares

Primary bedaquiline resistance in Karakalpakstan, Uzbekistan
por: Moe, S., et al.
Publicado: (2023)

Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan
por: Nair, P., et al.
Publicado: (2022)

Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan
por: Horter, Shona, et al.
Publicado: (2020)

Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan
por: Horter, Shona, et al.
Publicado: (2016)

Risk Factors Associated with Default from Multi- and Extensively Drug-Resistant Tuberculosis Treatment, Uzbekistan: A Retrospective Cohort Analysis
por: Lalor, Maeve K., et al.
Publicado: (2013)

Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan
por: du Cros, Philipp, et al.
Publicado: (2021)

Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan
por: Horter, Shona, et al.
Publicado: (2020)

Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan
por: Trauer, James M., et al.
Publicado: (2016)

Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005–2020), Republic of Karakalpakstan, Uzbekistan
por: Gadoev, Jamshid, et al.
Publicado: (2021)

2389. Surveillance evaluation of COVID-19 pharmacovigilance—Karakalpakstan, Uzbekistan, 2022
por: Tursinov, Yunis, et al.
Publicado: (2023)

Tuberculosis Recurrence and Mortality after Successful Treatment: Impact of Drug Resistance
por: Cox, Helen, et al.
Publicado: (2006)

Assessment of dietary exposure to some persistent organic pollutants in the Republic of Karakalpakstan of Uzbekistan.
por: Muntean, Nigina, et al.
Publicado: (2003)

Delay in the diagnosis and treatment of pulmonary tuberculosis in Uzbekistan: a cross-sectional study
por: Belkina, Tatiana V, et al.
Publicado: (2014)

The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan
por: Kohler, Stefan, et al.
Publicado: (2022)

Genetic Polymorphism of 27 Y-STR Loci in the Western Kazakh Tribes from Kazakhstan and Karakalpakstan, Uzbekistan
por: Ashirbekov, Yeldar, et al.
Publicado: (2022)

Programme costs of longer and shorter tuberculosis drug regimens and drug import: a modelling study for Karakalpakstan, Uzbekistan
por: Kohler, Stefan, et al.
Publicado: (2022)

Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study
por: Gadoev, Jamshid, et al.
Publicado: (2015)

MON-322 The Characteristic of Reproductive Disorders in Women with ACTH-Dependent Cushing Syndrome in the Republic of Uzbekistan (RUz) and Republic of Karakalpakstan (RKK)
por: Khalimova, Zamira Yusufovna, et al.
Publicado: (2020)

Health system support and health system strengthening: two key facilitators to the implementation of ambulatory tuberculosis treatment in Uzbekistan
por: Kohler, Stefan, et al.
Publicado: (2016)

Yield of Systematic Longitudinal Screening of Household Contacts of Pre-Extensively Drug Resistant (PreXDR) and Extensively Drug Resistant (XDR) Tuberculosis Patients in Mumbai, India
por: Paryani, Roma Haresh, et al.
Publicado: (2020)

Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India
por: Dhakulkar, Shubhangi, et al.
Publicado: (2021)

Contact investigation after a fatal case of extensively drug-resistant tuberculosis (XDR-TB) in an aircraft, Germany, July 2013
por: an der Heiden, Maria, et al.
Publicado: (2017)

Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
por: Metcalfe, John, et al.
Publicado: (2019)

XDR-TB in South Africa: Back to TB Sanatoria Perhaps?
por: Sakoane, Ramalitse
Publicado: (2007)

Risk Factors for Poor Treatment Outcomes in Patients with MDR-TB and XDR-TB in China: Retrospective Multi-Center Investigation
por: Tang, Shenjie, et al.
Publicado: (2013)

XDR-TB in South Africa: Revised Definition
por: Holtz, Timothy H
Publicado: (2007)

XDR-TB in South Africa: Detention Is Not the Priority
por: Goemaere, Eric, et al.
Publicado: (2007)

XDR-TB in South Africa: Theory and Practice
por: Andrews, Jason, et al.
Publicado: (2007)

Predictive factors for unfavourable treatment in MDR-TB and XDR-TB patients in Rio de Janeiro State, Brazil, 2000-2016
por: Bhering, Marcela, et al.
Publicado: (2019)

Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study
por: Das, Mrinalini, et al.
Publicado: (2021)

XDR-TB in South Africa: No Time for Denial or Complacency
por: Singh, Jerome Amir, et al.
Publicado: (2007)

Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan
por: Wharton-Smith, Alexandra, et al.
Publicado: (2021)

WHO's Response to Global Public Health Threats: XDR-TB
por: Wilson, Kumanan, et al.
Publicado: (2007)

Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use
por: Hafkin, Jeffrey, et al.
Publicado: (2017)

Extensively drug resistant tuberculosis (XDR-TB): A potential threat
por: Marwar, Anaga, et al.
Publicado: (2010)

Why and How the Old Neuroleptic Thioridazine Cures the XDR-TB Patient
por: Amaral, Leonard, et al.
Publicado: (2012)

Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
por: Chowdhury, Kona, et al.
Publicado: (2023)

Characteristics and Treatment Outcomes of Patients with MDR and XDR Tuberculosis in a TB Referral Hospital in Beijing: A 13-Year Experience
por: Liu, Cui Hua, et al.
Publicado: (2011)

Case report: Significant relief of linezolid-induced peripheral neuropathy in a pre-XDR-TB case after acupuncture treatment
por: Mo, Yuping, et al.
Publicado: (2022)

Early detection of Pre-XDR TB with line probe assay in a high TB burden country
por: Madukaji, Laura, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bdopidchceu3s7b1g55bqmomn2